Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

AIMS: With a prevalence of 16%, diabetes mellitus (DM) is one of the most frequent non‐communicable comorbidities of tuberculosis (TB). DM is a major risk factor for adverse TB outcomes and may require personalized TB drug dosing regimens. However, information on the inclusion of DM in TB drug trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutfiana, Nurul Cholifah, van Boven, Job F.M., Masoom Zubair, Muhammad Asim, Pena, Michelle J., Alffenaar, Jan‐Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595305/
https://www.ncbi.nlm.nih.gov/pubmed/30908689
http://dx.doi.org/10.1111/bcp.13935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595305/
https://www.ncbi.nlm.nih.gov/pubmed/30908689
http://dx.doi.org/10.1111/bcp.13935

Ejemplares similares